Revisiting the escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection, Contribution to intracellular biofilm development

Carlos C. Goller, Patrick C. Seed

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The treatment of urinary tract infections (UTIs) is becoming increasingly challenging as uropathogenic Escherichia coli (UPEC) becomes more resistant to the most widely prescribed oral antibiotics. The treatment of UTIs may also be complicated by the inherent lifestyle of UPEC in the urinary tract, revealed in recent studies demonstrating bacterial invasion into bladder epithelial cells, the formation of intracellular bacterial communities (IBCs; biofilmlike colonies in the host cell cytosol) and chronic intracellular persistence with subversion of normal immune surveillance. Identifying key targets in the pathogenesis of UTIs, including IBC formation, will be crucial to replenish the arsenal of treatments for UTIs. Focused on elucidating bacterial components that underpin the development of IBCs, Anderson et al. recently demonstrated a novel role for the K capsule polysaccharide in IBC formation. Without K capsule, intracellular UPEC failed to undergo normal IBC formation, the intracellular bacteria failed to preclude neutrophil infiltration, and UPEC did not undergo serial cycles of intracellular proliferation, resulting in attenuation of the infection. This study also demonstrated an interconnection between sialic acid homeostasis and IBC formation, demonstrating a unique role for this amino sugar in biofilm formation. This study provides evidence for an expanded role for K capsule in the intracellular and extracellular pathogenesis of UTI, and provides additional rationale for the development of small molecule inhibitors of capsule biogenesis as anti-virulence therapeutics.

Original languageEnglish (US)
Pages (from-to)333-337
Number of pages5
JournalVirulence
Volume1
Issue number4
DOIs
StatePublished - Jan 1 2010

Fingerprint

Uropathogenic Escherichia coli
Virulence Factors
Biofilms
Urinary Tract Infections
Capsules
Polysaccharides
Escherichia coli
Amino Sugars
Neutrophil Infiltration
N-Acetylneuraminic Acid
Urinary Tract
Cytosol
Virulence
Life Style
Urinary Bladder
Homeostasis
Epithelial Cells
Anti-Bacterial Agents
Bacteria
Infection

Keywords

  • Biofilm
  • Capsule
  • Escherichia coli
  • IBC
  • Intracellularbacterial communities
  • Polysaccharide
  • Sialic acid
  • Urinary tract infection
  • Virulence

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{63ace49efc7d4a31b2c788183f31ceed,
title = "Revisiting the escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection, Contribution to intracellular biofilm development",
abstract = "The treatment of urinary tract infections (UTIs) is becoming increasingly challenging as uropathogenic Escherichia coli (UPEC) becomes more resistant to the most widely prescribed oral antibiotics. The treatment of UTIs may also be complicated by the inherent lifestyle of UPEC in the urinary tract, revealed in recent studies demonstrating bacterial invasion into bladder epithelial cells, the formation of intracellular bacterial communities (IBCs; biofilmlike colonies in the host cell cytosol) and chronic intracellular persistence with subversion of normal immune surveillance. Identifying key targets in the pathogenesis of UTIs, including IBC formation, will be crucial to replenish the arsenal of treatments for UTIs. Focused on elucidating bacterial components that underpin the development of IBCs, Anderson et al. recently demonstrated a novel role for the K capsule polysaccharide in IBC formation. Without K capsule, intracellular UPEC failed to undergo normal IBC formation, the intracellular bacteria failed to preclude neutrophil infiltration, and UPEC did not undergo serial cycles of intracellular proliferation, resulting in attenuation of the infection. This study also demonstrated an interconnection between sialic acid homeostasis and IBC formation, demonstrating a unique role for this amino sugar in biofilm formation. This study provides evidence for an expanded role for K capsule in the intracellular and extracellular pathogenesis of UTI, and provides additional rationale for the development of small molecule inhibitors of capsule biogenesis as anti-virulence therapeutics.",
keywords = "Biofilm, Capsule, Escherichia coli, IBC, Intracellularbacterial communities, Polysaccharide, Sialic acid, Urinary tract infection, Virulence",
author = "Goller, {Carlos C.} and Seed, {Patrick C.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1126/science.1084550",
language = "English (US)",
volume = "1",
pages = "333--337",
journal = "Virulence",
issn = "2150-5594",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Revisiting the escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection, Contribution to intracellular biofilm development

AU - Goller, Carlos C.

AU - Seed, Patrick C.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The treatment of urinary tract infections (UTIs) is becoming increasingly challenging as uropathogenic Escherichia coli (UPEC) becomes more resistant to the most widely prescribed oral antibiotics. The treatment of UTIs may also be complicated by the inherent lifestyle of UPEC in the urinary tract, revealed in recent studies demonstrating bacterial invasion into bladder epithelial cells, the formation of intracellular bacterial communities (IBCs; biofilmlike colonies in the host cell cytosol) and chronic intracellular persistence with subversion of normal immune surveillance. Identifying key targets in the pathogenesis of UTIs, including IBC formation, will be crucial to replenish the arsenal of treatments for UTIs. Focused on elucidating bacterial components that underpin the development of IBCs, Anderson et al. recently demonstrated a novel role for the K capsule polysaccharide in IBC formation. Without K capsule, intracellular UPEC failed to undergo normal IBC formation, the intracellular bacteria failed to preclude neutrophil infiltration, and UPEC did not undergo serial cycles of intracellular proliferation, resulting in attenuation of the infection. This study also demonstrated an interconnection between sialic acid homeostasis and IBC formation, demonstrating a unique role for this amino sugar in biofilm formation. This study provides evidence for an expanded role for K capsule in the intracellular and extracellular pathogenesis of UTI, and provides additional rationale for the development of small molecule inhibitors of capsule biogenesis as anti-virulence therapeutics.

AB - The treatment of urinary tract infections (UTIs) is becoming increasingly challenging as uropathogenic Escherichia coli (UPEC) becomes more resistant to the most widely prescribed oral antibiotics. The treatment of UTIs may also be complicated by the inherent lifestyle of UPEC in the urinary tract, revealed in recent studies demonstrating bacterial invasion into bladder epithelial cells, the formation of intracellular bacterial communities (IBCs; biofilmlike colonies in the host cell cytosol) and chronic intracellular persistence with subversion of normal immune surveillance. Identifying key targets in the pathogenesis of UTIs, including IBC formation, will be crucial to replenish the arsenal of treatments for UTIs. Focused on elucidating bacterial components that underpin the development of IBCs, Anderson et al. recently demonstrated a novel role for the K capsule polysaccharide in IBC formation. Without K capsule, intracellular UPEC failed to undergo normal IBC formation, the intracellular bacteria failed to preclude neutrophil infiltration, and UPEC did not undergo serial cycles of intracellular proliferation, resulting in attenuation of the infection. This study also demonstrated an interconnection between sialic acid homeostasis and IBC formation, demonstrating a unique role for this amino sugar in biofilm formation. This study provides evidence for an expanded role for K capsule in the intracellular and extracellular pathogenesis of UTI, and provides additional rationale for the development of small molecule inhibitors of capsule biogenesis as anti-virulence therapeutics.

KW - Biofilm

KW - Capsule

KW - Escherichia coli

KW - IBC

KW - Intracellularbacterial communities

KW - Polysaccharide

KW - Sialic acid

KW - Urinary tract infection

KW - Virulence

UR - http://www.scopus.com/inward/record.url?scp=77954983629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954983629&partnerID=8YFLogxK

U2 - 10.1126/science.1084550

DO - 10.1126/science.1084550

M3 - Article

C2 - 21178466

AN - SCOPUS:77954983629

VL - 1

SP - 333

EP - 337

JO - Virulence

JF - Virulence

SN - 2150-5594

IS - 4

ER -